4//SEC Filing
Tada Hiroomi 4
Accession 0001209191-22-049218
CIK 0001863127other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 5:52 PM ET
Size
11.8 KB
Accession
0001209191-22-049218
Insider Transaction Report
Form 4
Tada Hiroomi
Chief Medical Officer
Transactions
- Award
Common Stock
2022-03-15$8.53/sh+2,703$23,044→ 80,625 total - Award
Stock Option (Right to Buy)
2022-09-06+110,000→ 110,000 totalExercise: $7.14Exp: 2032-09-05→ Common Stock (110,000 underlying)
Footnotes (2)
- [F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
- [F2]1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001880593
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 5:52 PM ET
- Size
- 11.8 KB